These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 8477851)

  • 1. Human neuroblastoma cells produce the NF-kappa B-like HIV-1 transcription activator during differentiation.
    Kurata S; Wakabayashi T; Ito Y; Miwa N; Ueno R; Marunouchi T; Kurata N
    FEBS Lett; 1993 Apr; 321(2-3):201-4. PubMed ID: 8477851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of nuclear factor kappa B in human neuroblastoma cell lines.
    Körner M; Tarantino N; Pleskoff O; Lee LM; Debré P
    J Neurochem; 1994 May; 62(5):1716-26. PubMed ID: 8158122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidoreductive regulation of nuclear factor kappa B. Involvement of a cellular reducing catalyst thioredoxin.
    Hayashi T; Ueno Y; Okamoto T
    J Biol Chem; 1993 May; 268(15):11380-8. PubMed ID: 8496188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF-kappa B site-mediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells.
    Mondal D; Alam J; Prakash O
    J Mol Neurosci; 1994-1995; 5(4):241-58. PubMed ID: 7577367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine augmentation of HIV-1 LTR-driven gene expression in neural cells.
    Swingler S; Easton A; Morris A
    AIDS Res Hum Retroviruses; 1992 Apr; 8(4):487-93. PubMed ID: 1599755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication by transcriptional activation at the long terminal repeat.
    Zhang Y; Nakata K; Weiden M; Rom WN
    J Clin Invest; 1995 May; 95(5):2324-31. PubMed ID: 7738195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential activation of human immunodeficiency virus type 1 and 2 transcription by specific T-cell activation signals.
    Hannibal MC; Markovitz DM; Clark N; Nabel GJ
    J Virol; 1993 Aug; 67(8):5035-40. PubMed ID: 8331739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The c-rel protooncogene product represses NF-kappa B p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus.
    Doerre S; Sista P; Sun SC; Ballard DW; Greene WC
    Proc Natl Acad Sci U S A; 1993 Feb; 90(3):1023-7. PubMed ID: 8430069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of HIV-1 LTR trans-activating activities in two different human hepatocellular carcinoma cell lines.
    Chang KS; Hsu ML; Josephs SF
    Cancer Lett; 1993 Oct; 74(1-2):75-83. PubMed ID: 8287375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
    Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
    Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of NF-kappa B during monocyte differentiation is associated with activation of HIV-gene expression.
    Griffin GE; Leung K; Folks TM; Kunkel S; Nabel GJ
    Res Virol; 1991; 142(2-3):233-8. PubMed ID: 1896645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding.
    Ganchi PA; Sun SC; Greene WC; Ballard DW
    Mol Biol Cell; 1992 Dec; 3(12):1339-52. PubMed ID: 1493333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus-1 infection of the human promyelocytic cell line HL-60: high frequency of low-level infection and effect of subsequent cell differentiation.
    Cannon PM; Tenen DG; Feinberg MB; Shin HS; Kim S
    Blood; 1993 Jan; 81(2):437-45. PubMed ID: 8422463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2).
    Burysek L; Yeow WS; Pitha PM
    J Hum Virol; 1999; 2(1):19-32. PubMed ID: 10200596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elements in the long terminal repeat of HIV-1 that interact with nuclear extracts from Jurkat cells persistently infected with vaccinia virus.
    Chang PY; Stellrecht K; Melana S; Pogo BG
    Virus Res; 1994 Nov; 34(2):127-38. PubMed ID: 7856307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-IL6-mediated transcriptional activation of the long terminal repeat of the human immunodeficiency virus type 1.
    Tesmer VM; Rajadhyaksha A; Babin J; Bina M
    Proc Natl Acad Sci U S A; 1993 Aug; 90(15):7298-302. PubMed ID: 8346247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-kappa B-binding proteins induced by HSV-1 infection of U937 cells are not involved in activation of human immunodeficiency virus.
    Feng CP; Kulka M; Aurelian L
    Virology; 1993 Feb; 192(2):491-500. PubMed ID: 8380662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of HIV type 1 gene expression and induction of NF-kappa B (p50/p65)-binding activity in tumor necrosis factor alpha-treated human fetal glial cells.
    Atwood WJ; Tornatore CS; Traub R; Conant K; Drew PD; Major EO
    AIDS Res Hum Retroviruses; 1994 Oct; 10(10):1207-11. PubMed ID: 7848678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of CCAAT/enhancer-binding protein and nuclear factor-kappa B binding sites in interleukin-6 promoter inhibition by estrogens.
    Galien R; Evans HF; Garcia T
    Mol Endocrinol; 1996 Jun; 10(6):713-22. PubMed ID: 8776731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus type 1 long terminal repeat quasispecies differ in basal transcription and nuclear factor recruitment in human glial cells and lymphocytes.
    Krebs FC; Mehrens D; Pomeroy S; Goodenow MM; Wigdahl B
    J Biomed Sci; 1998; 5(1):31-44. PubMed ID: 9570512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.